Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 215, Issue 5, Pages 539-547Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2016.06.038
Keywords
alcohol; brief intervention; opioid use; pregnancy; referral to treatment; screening; substance use disorders; tobacco
Categories
Funding
- NIDA NIH HHS [R01 DA027194] Funding Source: Medline
Ask authors/readers for more resources
Substance use during pregnancy is at least as common as many of the medical conditions screened for and managed during pregnancy. While harmful and costly, it is often ignored or managed poorly. Screening, brief intervention, and referral to treatment is an evidence-based approach to manage substance use. In September 2012, the US Centers for Disease Control and Prevention convened an Expert Meeting on Perinatal Illicit Drug Abuse to help address key issues around drug use in pregnancy in the United States. This article reflects the formal conclusions of the expert panel that discussed the use of screening, brief intervention, and referral to treatment during pregnancy. Screening for substance use during pregnancy should be universal. It allows stratification of women into zones of risk given their pattern of use. Low-risk women should receive brief advice, those classified as moderate risk should receive a brief intervention, whereas those who are high risk need referral to specialty care. A brief intervention is a patient-centered form of counseling using the principles of motivational interviewing. Screening, brief intervention, and referral to treatment has the potential to reduce the burden of substance use in pregnancy and should be integrated into prenatal care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available